menu
    • menu

    Company profile for ASLAN Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ASLAN Pharmaceuticals is a clinical-stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets. We target diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Founded in 2010, ASLAN has rapidly established a strong track record in oncology-focused product development. Since our founding, we have raised over US$167 million i...
    ASLAN Pharmaceuticals is a clinical-stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets. We target diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Founded in 2010, ASLAN has rapidly established a strong track record in oncology-focused product development. Since our founding, we have raised over US$167 million in financing, formed innovative partnerships with pharmaceutical industry leaders and developed four therapeutic medicines that target cancers for which there are few effective treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ASLAN PharmaceuticalsSingapore Flag
    Country
    Country
    Singapore
    Address
    Address
    83 Clemenceau Avenue #12-03 UE Square Singapore 239920
    Telephone
    Telephone
    +65 6222 4235
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://aslanpharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/aslan-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aslan’s dream of challenging Dupixent dies as cash-strapped biotech winds down
    Aslan’s dream of challenging Dupixent dies as cash-strapped biotech winds down

    17 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aslans-dream-challenging-dupixent-dies-cash-strapped-biotech-winds-down

    FIERCE BIOTECH
    17 Jul 2024
    Share Share
    ASLAN Pharmaceuticals Files For Voluntary Liquidation
    ASLAN Pharmaceuticals Files For Voluntary Liquidation

    17 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/17/2914447/0/en/ASLAN-Pharmaceuticals-Announces-it-Has-Filed-for-Voluntary-Liquidation-of-Its-Sole-Operating-Subsidiary-and-is-Commencing-Steps-to-Place-Itself-Into-Voluntary-Liquidation.html

    GLOBENEWSWIRE
    17 Jul 2024
    Share Share
    ASLAN Pharmaceuticals Receives Nasdaq Delisting Determination
    ASLAN Pharmaceuticals Receives Nasdaq Delisting Determination

    15 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/15/2912960/0/en/ASLAN-Pharmaceuticals-Announces-Receipt-of-Nasdaq-Delisting-Determination-Has-Determined-Not-to-Appeal.html

    GLOBENEWSWIRE
    15 Jul 2024
    Share Share
    ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
    ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change

    14 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/14/2899196/0/en/ASLAN-Pharmaceuticals-Announces-Plan-to-Implement-ADS-Ratio-Change.html

    GLOBENEWSWIRE
    14 Jun 2024
    Share Share
    ASLAN Presents Eblasakimab COPD Translational Data At ATS
    ASLAN Presents Eblasakimab COPD Translational Data At ATS

    21 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/21/2885431/0/en/ASLAN-Pharmaceuticals-Presents-Late-Breaking-Translational-Data-on-Eblasakimab-in-COPD-at-the-American-Thoracic-Society-International-Conference.html

    GLOBENEWSWIRE
    21 May 2024
    Share Share
    ASLAN Pharma Q1 2024 Financials And Corporate Update
    ASLAN Pharma Q1 2024 Financials And Corporate Update

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2878618/0/en/ASLAN-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search